Target Binding Site Detail

Content Navigation (  All   None )                                      
Target General Information
Ligand General Information
Drug Binding Sites of Target
References
Target General Information  Top
Target ID T40474 Target Info
Target Name Proto-oncogene c-Met (MET)
Synonyms Tyrosine-protein kinase Met; Scatter factor receptor; SF receptor; Met proto-oncogene tyrosine kinase; Hepatocyte growth factor receptor; HGF/SF receptor; HGF-SF receptor; HGF receptor; C-met; C-Met receptor tyrosine kinase
Target Type Successful Target
Gene Name MET
Biochemical Class Kinase
UniProt ID
MET_HUMAN
Ligand General Information  Top
Ligand Name SGX523 Ligand Info
Canonical SMILES CN1C=C(C=N1)C2=NN3C(=NN=C3SC4=CC5=C(C=C4)N=CC=C5)C=C2
InChI 1S/C18H13N7S/c1-24-11-13(10-20-24)16-6-7-17-21-22-18(25(17)23-16)26-14-4-5-15-12(9-14)3-2-8-19-15/h2-11H,1H3
InChIKey BCZUAADEACICHN-UHFFFAOYSA-N
PubChem Compound ID 24779724
Drug Binding Sites of Target  Top
PDB ID: 3DKF      Structure of MET receptor tyrosine kinase in complex with inhibitor SGX-523
Method X-ray diffraction Resolution 1.80 Å Mutation Yes [1]
PDB Sequence
TVHIDLSALN
1059
PELVQAVQHV
1069
VIGPSSLIVH
1079
FNEVIGRGHF
1089
GCVYHGTLKK
1104

IHCAVKSLNR
1114
ITDIGEVSQF
1124
LTEGIIMKDF
1134
SHPNVLSLLG
1144
ICLRSEGSPL
1154

VVLPYMKHGD
1164
LRNFIRNETH
1174
NPTVKDLIGF
1184
GLQVAKGMKF
1194
LASKKFVHRD
1204

LAARNCMLDE
1214
KFTVKVADFG
1224
LARDMYKLPV
1247
KWMALESLQT
1257
QKFTTKSDVW
1267

SFGVLLWELM
1277
TRGAPPYPDV
1287
NTFDITVYLL
1297
QGRRLLQPEY
1307
CPDPLYEVML
1317

KCWHPKAEMR
1327
PSFSELVSRI
1337
SAIFSTFIGE
1347
HYVHVNATYV
1357
NVKE
Residue
Distance (Å)
ILE1084
3.659
GLY1085
4.763
VAL1092
3.848
ALA1108
3.524
LEU1140
3.736
LEU1157
3.742
PRO1158
3.598
TYR1159
3.663
MET1160
2.927
ASP1164
3.127
Residue
Distance (Å)
ASN1167
3.836
ARG1208
3.391
ASN1209
3.985
CYS1210
4.958
MET1211
3.561
ALA1221
3.266
ASP1222
2.905
ALA1226
3.450
TYR1230
3.414
PDB ID: 3DKG      Structure of Mutant(Y1248L) MET receptor tyrosine kinase in complex with inhibitor SGX-523
Method X-ray diffraction Resolution 1.91 Å Mutation Yes [1]
PDB Sequence
TVHIDLSALN
1059
PELVQAVQHV
1069
VIGPSSLIVH
1079
FNEVICVYHG
1095
TLLDKKIHCA
1108

VKSLNRITDI
1118
GEVSQFLTEG
1128
IIMKDFSHPN
1138
VLSLLGICLR
1148
SEGSPLVVLP
1158

YMKHGDLRNF
1168
IRNETHNPTV
1178
KDLIGFGLQV
1188
AKGMKFLASK
1198
KFVHRDLAAR
1208

NCMLDEKFTV
1218
KVADFGLARL
1245
PVKWMALESL
1255
QTQKFTTKSD
1265
VWSFGVLLWE
1275

LMTRGAPPYP
1285
DVNTFDITVY
1295
LLQGRRLLQP
1305
EYCPDPLYEV
1315
MLKCWHPKAE
1325

MRPSFSELVS
1335
RISAIFSTFI
1345
GEHYVHVNAT
1355
Y
Residue
Distance (Å)
ILE1084
3.282
VAL1092
4.292
ALA1108
3.351
LEU1140
3.856
LEU1157
3.747
PRO1158
3.532
TYR1159
3.441
MET1160
2.748
LYS1161
4.868
Residue
Distance (Å)
ASP1164
3.131
ASN1167
3.795
ARG1208
3.374
ASN1209
3.989
CYS1210
4.949
MET1211
3.531
ALA1221
3.299
ASP1222
2.911
ALA1226
3.332
References  Top
REF 1 SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo. Mol Cancer Ther. 2009 Dec;8(12):3181-90.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.